Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Imunon Debt to Equity Ratio 2011-2025 | IMNN

Current and historical debt to equity ratio values for Imunon (IMNN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Imunon debt/equity for the three months ending September 30, 2025 was 0.00.
Imunon Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-09-30 $0.01B $0.00B 1.20
2025-06-30 $0.01B $0.00B 2.30
2025-03-31 $0.01B $0.00B 14.18
2024-12-31 $0.01B $0.00B 1.29
2024-09-30 $0.01B $0.01B 0.76
2024-06-30 $0.01B $0.00B 1.59
2024-03-31 $0.01B $0.01B 0.69
2023-12-31 $0.01B $0.01B 0.64
2023-09-30 $0.01B $0.02B 0.36
2023-06-30 $0.01B $0.02B 0.34
2023-03-31 $0.02B $0.03B 0.58
2022-12-31 $0.02B $0.03B 0.50
2022-09-30 $0.02B $0.04B 0.46
2022-06-30 $0.02B $0.05B 0.39
2022-03-31 $0.02B $0.05B 0.39
2021-12-31 $0.02B $0.06B 0.33
2021-09-30 $0.02B $0.06B 0.34
2021-06-30 $0.02B $0.06B 0.30
2021-03-31 $0.02B $0.06B 0.33
2020-12-31 $0.02B $0.02B 1.02
2020-09-30 $0.02B $0.02B 1.00
2020-06-30 $0.02B $0.02B 0.93
2020-03-31 $0.02B $0.02B 1.40
2019-12-31 $0.02B $0.02B 1.63
2019-09-30 $0.03B $0.02B 1.62
2019-06-30 $0.03B $0.02B 1.32
2019-03-31 $0.02B $0.02B 1.12
2018-12-31 $0.03B $0.02B 1.25
2018-09-30 $0.03B $0.02B 1.70
2018-06-30 $0.03B $0.02B 1.59
2018-03-31 $0.02B $0.02B 0.86
2017-12-31 $0.02B $0.03B 0.78
2017-09-30 $0.02B $0.01B 3.92
2017-06-30 $0.02B $0.01B 3.46
2017-03-31 $0.03B $0.01B 4.04
2016-12-31 $0.02B $0.01B 3.59
2016-09-30 $0.03B $0.01B 2.54
2016-06-30 $0.03B $0.02B 1.64
2016-03-31 $0.03B $0.02B 1.83
2015-12-31 $0.03B $0.02B 1.41
2015-09-30 $0.03B $0.03B 1.14
2015-06-30 $0.03B $0.03B 1.08
2015-03-31 $0.03B $0.03B 1.24
2014-12-31 $0.03B $0.03B 1.03
2014-09-30 $0.04B $0.04B 0.89
2014-06-30 $0.03B $0.05B 0.75
2014-03-31 $0.01B $0.04B 0.35
2013-12-31 $0.01B $0.03B 0.45
2013-09-30 $0.02B $0.03B 0.63
2013-06-30 $0.02B $0.03B 0.55
2013-03-31 $0.02B $0.03B 0.49
2012-12-31 $0.01B $0.01B 1.12
2012-09-30 $0.01B $0.01B 0.95
2012-06-30 $0.01B $0.02B 0.82
2012-03-31 $0.01B $0.02B 0.33
2011-12-31 $0.01B $0.03B 0.25
2011-09-30 $0.01B $0.02B 0.27
2011-06-30 $0.01B $0.00B 13.08
2011-03-31 $0.01B $-0.01B -1.95
2010-12-31 $0.01B $-0.01B -1.55
2010-09-30 $0.01B $0.00B -5.99
2010-06-30 $0.00B $0.00B 2.09
2010-03-31 $0.01B $0.00B 1.51
2009-12-31 $0.01B $0.01B 0.48
2009-09-30 $0.01B $0.01B 0.47
2009-06-30 $0.01B $0.01B 0.40
2009-03-31 $0.00B $0.02B 0.24
2008-12-31 $0.00B $0.02B 0.20
2008-09-30 $0.01B $0.02B 0.27
2008-06-30 $0.01B $0.03B 0.22
2008-03-31 $0.01B $0.03B 0.26
2007-12-31 $0.01B $0.03B 0.27
2007-09-30 $0.01B $0.04B 0.25
2007-06-30 $0.01B $0.04B 0.26
2007-03-31 $0.02B $-0.01B -4.11
2006-12-31 $0.02B $0.00B -6.91
2006-09-30 $0.02B $0.00B -10.20
2006-06-30 $0.02B $0.00B -11.68
2006-03-31 $0.02B $0.00B 7.88
2005-12-31 $0.01B $0.00B 3.64
2005-09-30 $0.01B $0.01B 2.17
2005-06-30 $0.01B $0.01B 0.83
2005-03-31 $0.01B $0.01B 0.57
2004-12-31 $0.01B $0.01B 0.42
2004-09-30 $0.01B $0.02B 0.38
2004-06-30 $0.01B $0.02B 0.33
2004-03-31 $0.01B $0.02B 0.36
2003-12-31 $0.00B $0.01B 0.07
2003-09-30 $0.00B $0.01B 0.12
2003-06-30 $0.00B $0.01B 0.18
2003-03-31 $0.00B $0.00B 0.25
2002-12-31 $0.00B $0.00B 1.17
2002-09-30 $0.00B $0.00B 0.51
2002-06-30 $0.00B $0.00B 0.22
2002-03-31 $0.00B $0.00B 0.19
2001-12-31 $0.00B $0.01B 0.01
2001-09-30 $0.00B $0.00B 0.11
2001-06-30 $0.00B $0.01B 0.06
2001-03-31 $0.00B $0.01B 0.04
2000-12-31 $0.00B $0.01B 0.06
2000-09-30 $0.00B $0.01B 0.05
2000-06-30 $0.00B $0.01B 0.04
2000-03-31 $0.00B $0.01B 0.06
1999-12-31 $0.00B $0.00B 0.49
1999-09-30 $0.00B $0.00B 0.51
1999-06-30 $0.00B $0.00B 0.83
1999-03-31 $0.00B $0.00B -1.29
1998-12-31 $0.00B $0.00B -1.17
1998-09-30 $0.00B $0.00B -1.18
1998-06-30 $0.00B $0.00B -1.25
1998-03-31 $0.00B $0.00B -1.68
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.012B $0.001B
Imunon Inc. is a fully integrated, clinical stage biotechnology company. It focused on advancing a portfolio of treatments which harness the body's natural mechanisms. The company's lead clinical program includes GEN-1. Imunon Inc., formerly known as Celsion Corporation, is based in LAWRENCEVILLE, N.J.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $277.266B 19.56
Amgen (AMGN) United States $184.004B 15.62
Gilead Sciences (GILD) United States $153.956B 15.15
Vertex Pharmaceuticals (VRTX) United States $110.119B 28.35
GSK (GSK) United Kingdom $96.506B 10.73
Bristol Myers Squibb (BMY) United States $95.294B 7.14
Regeneron Pharmaceuticals (REGN) United States $74.023B 19.20
Alnylam Pharmaceuticals (ALNY) United States $60.844B 2002.35
Argenex SE (ARGX) Netherlands $57.235B 71.07
CSL (CSLLY) Australia $56.239B 0.00
Insmed (INSM) United States $42.100B 0.00
Novozymes (NVZMY) Denmark $29.639B 0.00
BioNTech SE (BNTX) Germany $24.688B 0.00
Biogen (BIIB) United States $24.159B 9.84
Royalty Pharma (RPRX) United States $22.605B 8.66
Incyte (INCY) United States $20.451B 19.58
Genmab (GNMSF) Denmark $20.153B 14.78
Genmab (GMAB) Denmark $19.532B 14.70
Illumina (ILMN) United States $18.348B 27.54
Roivant Sciences (ROIV) United Kingdom $14.040B 0.00
Revolution Medicines (RVMD) United States $13.366B 0.00
Ascendis Pharma (ASND) Denmark $13.361B 0.00
Exact Sciences (EXAS) United States $12.723B 353.42
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Guardant Health (GH) United States $12.160B 0.00
Exelixis (EXEL) United States $11.373B 18.21
Avidity Biosciences (RNA) United States $10.650B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.463B 18.98
Jazz Pharmaceuticals (JAZZ) Ireland $10.336B 40.31
QIAGEN (QGEN) Netherlands $9.810B 18.62
Moderna (MRNA) United States $9.675B 0.00
Bio-Techne Corp (TECH) United States $9.132B 34.08
Abivax SA (ABVX) France $8.843B 0.00
Repligen (RGEN) United States $8.387B 89.76
Bio-Rad Laboratories (BIO.B) United States $8.381B 30.14
Halozyme Therapeutics (HALO) United States $8.298B 13.26
Cytokinetics (CYTK) United States $8.186B 0.00
Nuvalent (NUVL) United States $7.852B 0.00
Axsome Therapeutics (AXSM) United States $7.338B 0.00
Merus (MRUS) Netherlands $7.272B 0.00
Cidara Therapeutics (CDTX) United States $6.851B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.720B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.394B 0.00
Vaxcyte (PCVX) United States $6.328B 0.00
PTC Therapeutics (PTCT) United States $6.070B 8.24
Krystal Biotech (KRYS) United States $6.039B 31.22
Zealand Pharma (ZLDPF) Denmark $5.646B 5.72
Arrowhead Pharmaceuticals (ARWR) United States $5.551B 0.00
Legend Biotech (LEGN) United States $5.485B 0.00
Protagonist Therapeutics (PTGX) United States $5.299B 136.73
CRISPR Therapeutics AG (CRSP) Switzerland $5.272B 0.00
Arcellx (ACLX) United States $5.224B 0.00
Praxis Precision Medicines (PRAX) United States $4.941B 0.00
TG Therapeutics (TGTX) United States $4.872B 11.04
Alkermes (ALKS) Ireland $4.843B 14.24
Cogent Biosciences (COGT) United States $4.805B 0.00
Kymera Therapeutics (KYMR) United States $4.612B 0.00
Akero Therapeutics (AKRO) United States $4.474B 0.00
Viking Therapeutics (VKTX) United States $4.320B 0.00
Celcuity (CELC) United States $4.268B 0.00
Immunovant (IMVT) United States $4.259B 0.00
Belite Bio (BLTE) United States $4.079B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.062B 34.30
Ligand Pharmaceuticals (LGND) United States $3.963B 97.27
Anbio Biotechnology (NNNN) Germany $3.920B 0.00
Scholar Rock Holding (SRRK) United States $3.720B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.711B 0.00
ADMA Biologics Inc (ADMA) United States $3.670B 26.14
Mineralys Therapeutics (MLYS) United States $3.503B 0.00
Disc Medicine (IRON) United States $3.384B 0.00
CG Oncology (CGON) United States $3.327B 0.00
GRAIL (GRAL) United States $3.311B 0.00
Arcutis Biotherapeutics (ARQT) United States $3.206B 0.00
Travere Therapeutics (TVTX) United States $3.171B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.148B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.139B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.138B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.138B 92.00
Telix Pharmaceuticals (TLX) Australia $3.103B 0.00
Ascentage Pharma Group - (AAPG) China $3.053B 0.00
Apogee Therapeutics (APGE) United States $2.989B 0.00
IDEAYA Biosciences (IDYA) United States $2.923B 0.00
Amicus Therapeutics (FOLD) United States $2.906B 235.50
Viridian Therapeutics (VRDN) United States $2.768B 0.00
Agios Pharmaceuticals (AGIO) United States $2.632B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.569B 0.00
Denali Therapeutics (DNLI) United States $2.548B 0.00
Apellis Pharmaceuticals (APLS) United States $2.543B 64.84
Liquidia (LQDA) United States $2.471B 0.00
Edgewise Therapeutics (EWTX) United States $2.357B 0.00
Zai Lab (ZLAB) China $2.338B 0.00
Jyong Biotech (MENS) Taiwan $2.336B 0.00
Terns Pharmaceuticals (TERN) United States $2.302B 0.00
Beam Therapeutics (BEAM) United States $2.234B 0.00
Bavarian Nordic (BVNRY) Denmark $2.232B 6.06
Structure Therapeutics (GPCR) United States $2.164B 0.00
Arcus Biosciences (RCUS) United States $2.158B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.145B 0.00
Adaptive Biotechnologies (ADPT) United States $2.093B 0.00
ImmunityBio (IBRX) United States $1.999B 0.00
Vericel (VCEL) United States $1.994B 164.29
Harmony Biosciences Holdings (HRMY) United States $1.958B 10.69
Mesoblast (MESO) Australia $1.936B 0.00
Zenas BioPharma (ZBIO) United States $1.926B 0.00
Spyre Therapeutics (SYRE) United States $1.890B 0.00
UniQure (QURE) Netherlands $1.889B 0.00
Vera Therapeutics (VERA) United States $1.883B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.843B 0.00
ANI Pharmaceuticals (ANIP) United States $1.842B 14.28
Sarepta Therapeutics (SRPT) United States $1.838B 0.00
Zymeworks (ZYME) United States $1.789B 0.00
Sionna Therapeutics (SION) United States $1.782B 0.00
Dianthus Therapeutics (DNTH) United States $1.773B 0.00
Precigen (PGEN) United States $1.734B 0.00
Celldex Therapeutics (CLDX) United States $1.728B 0.00
Janux Therapeutics (JANX) United States $1.727B 0.00
Immunome (IMNM) United States $1.663B 0.00
Maze Therapeutics (MAZE) United States $1.613B 0.00
Nuvation Bio (NUVB) United States $1.601B 0.00
Twist Bioscience (TWST) United States $1.597B 0.00
Alvotech (ALVO) Luxembourg $1.550B 22.35
Stoke Therapeutics (STOK) United States $1.539B 40.22
MannKind (MNKD) United States $1.529B 49.80
Syndax Pharmaceuticals (SNDX) United States $1.493B 0.00
Trevi Therapeutics (TRVI) United States $1.455B 0.00
Upstream Bio (UPB) United States $1.389B 0.00
NeoGenomics (NEO) United States $1.322B 0.00
Dynavax Technologies (DVAX) United States $1.308B 38.41
Pharvaris (PHVS) Netherlands $1.303B 0.00
Certara (CERT) United States $1.301B 24.03
NovoCure (NVCR) Jersey $1.262B 0.00
Rapport Therapeutics (RAPP) United States $1.197B 0.00
WAVE Life Sciences (WVE) Singapore $1.195B 0.00
CureVac (CVAC) Germany $1.185B 5.50
Oric Pharmaceuticals (ORIC) United States $1.175B 0.00
Immatics (IMTX) Germany $1.151B 0.00
MBX Biosciences (MBX) United States $1.150B 0.00
Inhibrx Biosciences (INBX) United States $1.125B 0.00
Mind Medicine (MindMed) (MNMD) United States $1.117B 0.00
Pharming Group (PHAR) Netherlands $1.112B 0.00
Urogen Pharma (URGN) United States $1.109B 0.00
Novavax (NVAX) United States $1.105B 2.81
BridgeBio Oncology Therapeutics (BBOT) United States $1.098B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.087B 0.00
AbCellera Biologics (ABCL) Canada $1.078B 0.00
Tango Therapeutics (TNGX) United States $1.074B 0.00
Kodiak Sciences (KOD) United States $1.052B 0.00
MiMedx (MDXG) United States $1.052B 18.68
Nanobiotix S.A - (NBTX) France $1.049B 0.00
Pacira BioSciences (PCRX) United States $1.027B 11.76
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Phathom Pharmaceuticals (PHAT) United States $1.025B 0.00
Oculis Holding AG (OCS) Switzerland $1.003B 0.00
Castle Biosciences (CSTL) United States $0.991B 135.80
Nurix Therapeutics (NRIX) United States $0.983B 0.00
Intellia Therapeutics (NTLA) United States $0.982B 0.00
Sana Biotechnology (SANA) United States $0.970B 0.00
Septerna (SEPN) United States $0.969B 0.00
Palvella Therapeutics (PVLA) United States $0.966B 0.00
AnaptysBio (ANAB) United States $0.963B 0.00
Iovance Biotherapeutics (IOVA) United States $0.961B 0.00
Rezolute (RZLT) United States $0.948B 0.00
Kura Oncology (KURA) United States $0.944B 0.00
Atai Beckley N.V (ATAI) Germany $0.926B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.908B 0.00
Fortrea Holdings (FTRE) United States $0.905B 19.20
Monte Rosa Therapeutics (GLUE) United States $0.886B 42.53
BGM Group (BGM) China $0.885B 0.00
Biohaven (BHVN) United States $0.875B 0.00
Arbutus Biopharma (ABUS) United States $0.873B 0.00
Compass Therapeutics (CMPX) United States $0.870B 0.00
ArriVent BioPharma (AVBP) United States $0.854B 0.00
Tyra Biosciences (TYRA) United States $0.849B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $0.834B 0.00
Bicara Therapeutics (BCAX) United States $0.824B 0.00
Erasca (ERAS) United States $0.814B 0.00
LENZ Therapeutics (LENZ) United States $0.804B 0.00
Rapt Therapeutics (RAPT) United States $0.794B 0.00
CorMedix Inc (CRMD) United States $0.786B 7.28
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.781B 0.00
Gyre Therapeutics (GYRE) United States $0.773B 100.25
Vir Biotechnology (VIR) United States $0.764B 0.00
GH Research (GHRS) Ireland $0.734B 0.00
Geron (GERN) United States $0.721B 0.00
Astria Therapeutics (ATXS) United States $0.718B 0.00
Arvinas (ARVN) United States $0.709B 0.00
Gossamer Bio (GOSS) United States $0.692B 0.00
Prime Medicine (PRME) United States $0.690B 0.00
Replimune (REPL) United States $0.688B 0.00
Ventyx Biosciences (VTYX) United States $0.678B 0.00
Cytek Biosciences (CTKB) United States $0.676B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.665B 0.00
Invivyd (IVVD) United States $0.662B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
MeiraGTx Holdings (MGTX) United States $0.634B 0.00
Myriad Genetics (MYGN) United States $0.621B 0.00
Verastem (VSTM) United States $0.611B 0.00
CytomX Therapeutics (CTMX) United States $0.602B 8.88
Evommune (EVMN) $0.585B 0.00
Olema Pharmaceuticals (OLMA) United States $0.585B 0.00
Opthea (OPT) Australia $0.583B 0.00
Alumis (ALMS) United States $0.580B 0.00
MapLight Therapeutics (MPLT) United States $0.567B 0.00
Inventiva S.A (IVA) France $0.565B 0.00
REGENXBIO (RGNX) United States $0.564B 0.00
Niagen Bioscience (NAGE) United States $0.553B 43.31
Prothena (PRTA) Ireland $0.552B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.531B 0.00
Emergent Biosolutions (EBS) United States $0.530B 5.10
Keros Therapeutics (KROS) United States $0.529B 11.28
Fulcrum Therapeutics (FULC) United States $0.522B 0.00
Cullinan Therapeutics (CGEM) United States $0.518B 0.00
Monopar Therapeutics (MNPR) United States $0.511B 0.00
NovaBridge Biosciences (NBP) United States $0.504B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.492B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.471B 0.00
Eton Pharmaceuticals (ETON) United States $0.463B 0.00
Benitec Biopharma (BNTC) United States $0.458B 0.00
DBV Technologies S.A (DBVT) France $0.456B 0.00
Bright Minds Biosciences (DRUG) United States $0.452B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.448B 0.00
Neumora Therapeutics (NMRA) United States $0.433B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.431B 0.00
Absci (ABSI) United States $0.430B 0.00
Alto Neuroscience (ANRO) United States $0.429B 0.00
Design Therapeutics (DSGN) United States $0.423B 0.00
EnGene Holdings (ENGN) Canada $0.413B 0.00
Jade Biosciences (JBIO) United States $0.411B 0.00
XOMA Royalty (XOMA) United States $0.397B 0.00
Kamada (KMDA) Israel $0.393B 19.00
PureTech Health (PRTC) United States $0.387B 0.00
Ocugen (OCGN) United States $0.362B 0.00
Annexon (ANNX) United States $0.361B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.357B 0.00
Northwest Biotherapeutics (NWBO) United States $0.356B 0.00
Aura Biosciences (AURA) United States $0.349B 0.00
Neurogene (NGNE) United States $0.348B 0.00
Tectonic Therapeutic (TECX) United States $0.344B 0.00
Solid Biosciences (SLDB) United States $0.338B 0.00
DiaMedica Therapeutics (DMAC) United States $0.334B 0.00
Amarin (AMRN) Ireland $0.334B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.329B 0.00
Contineum Therapeutics (CTNM) United States $0.325B 0.00
Entrada Therapeutics (TRDA) United States $0.324B 0.00
X4 Pharmaceuticals (XFOR) United States $0.320B 0.00
Kyverna Therapeutics (KYTX) United States $0.314B 0.00
AC Immune (ACIU) Switzerland $0.311B 0.00
Palisade Bio (PALI) United States $0.308B 0.00
Anavex Life Sciences (AVXL) United States $0.308B 0.00
BioAge Labs (BIOA) United States $0.298B 0.00
Lifecore Biomedical (LFCR) United States $0.296B 0.00
Immuneering (IMRX) United States $0.288B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.281B 0.00
Allogene Therapeutics (ALLO) United States $0.276B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.274B 0.00
Prima BioMed (IMMP) Australia $0.272B 0.00
Foghorn Therapeutics (FHTX) United States $0.272B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.260B 0.00
Candel Therapeutics (CADL) United States $0.260B 0.00
Zura Bio (ZURA) United States $0.259B 0.00
Sagimet Biosciences (SGMT) United States $0.254B 0.00
Editas Medicine (EDIT) United States $0.252B 0.00
Puma Biotechnology (PBYI) United States $0.250B 6.70
Adherex Technologies (FENC) United States $0.246B 0.00
Abeona Therapeutics (ABEO) United States $0.244B 3.99
C4 Therapeutics (CCCC) United States $0.242B 0.00
Nautilus Biotechnology (NAUT) United States $0.240B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.237B 0.00
Atea Pharmaceuticals (AVIR) United States $0.236B 0.00
Rani Therapeutics Holdings (RANI) United States $0.236B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.233B 0.00
GENFIT S.A (GNFT) France $0.231B 0.00
Cabaletta Bio (CABA) United States $0.230B 0.00
Alpha Teknova (TKNO) United States $0.229B 0.00
Voyager Therapeutics (VYGR) United States $0.229B 0.00
Black Diamond Therapeutics (BDTX) United States $0.228B 11.14
Aardvark Therapeutics (AARD) United States $0.226B 0.00
Adocia (ADOCY) France $0.216B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.216B 0.00
Tenaya Therapeutics (TNYA) United States $0.210B 0.00
SELLAS Life Sciences (SLS) United States $0.201B 0.00
Genelux (GNLX) United States $0.200B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.198B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.198B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.197B 0.00
Seres Therapeutics (MCRB) United States $0.196B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.192B 0.00
Cartesian Therapeutics (RNAC) United States $0.192B 0.00
CAMP4 Therapeutics (CAMP) United States $0.187B 0.00
Crescent Biopharma (CBIO) United States $0.182B 0.00
Forte Biosciences (FBRX) United States $0.182B 0.00
Humacyte (HUMA) United States $0.179B 0.00
Caribou Biosciences (CRBU) United States $0.177B 0.00
PepGen (PEPG) United States $0.175B 0.00
VistaGen Therapeutics (VTGN) United States $0.175B 0.00
MaxCyte (MXCT) United States $0.174B 0.00
Molecular Partners AG (MOLN) Switzerland $0.172B 0.00
Innate Pharma S.A (IPHA) France $0.168B 0.00
Nuvectis Pharma (NVCT) United States $0.156B 0.00
Elicio Therapeutics (ELTX) United States $0.153B 0.00
Agenus (AGEN) United States $0.147B 0.00
Compugen (CGEN) Israel $0.142B 0.00
Codexis (CDXS) United States $0.142B 0.00
Connect Biopharma Holdings (CNTB) United States $0.139B 0.00
Anika Therapeutics (ANIK) United States $0.139B 0.00
Cardiff Oncology (CRDF) United States $0.139B 0.00
Mersana Therapeutics (MRSN) United States $0.139B 0.00
Sangamo Therapeutics (SGMO) United States $0.138B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.138B 0.00
Actuate Therapeutics (ACTU) United States $0.138B 0.00
Spero Therapeutics (SPRO) United States $0.137B 0.00
Coherus Oncology (CHRS) United States $0.137B 0.00
Immix Biopharma (IMMX) United States $0.136B 0.00
Alector (ALEC) United States $0.135B 0.00
Cognition Therapeutics (CGTX) United States $0.134B 0.00
Inovio Pharmaceuticals (INO) United States $0.132B 0.00
Nkarta (NKTX) United States $0.129B 0.00
Alpha Cognition (ACOG) Canada $0.128B 0.00
Climb Bio (CLYM) United States $0.128B 0.00
Shattuck Labs (STTK) United States $0.125B 0.00
EXoZymes (EXOZ) United States $0.125B 0.00
Entera Bio (ENTX) Israel $0.123B 0.00
Coya Therapeutics (COYA) United States $0.122B 0.00
Opus Genetics (IRD) United States $0.120B 0.00
VTv Therapeutics (VTVT) United States $0.119B 0.00
Scilex Holding (SCLX) United States $0.118B 0.00
Greenwich LifeSciences (GLSI) United States $0.114B 0.00
Fate Therapeutics (FATE) United States $0.112B 0.00
Seer (SEER) United States $0.112B 0.00
BioHarvest Sciences (BHST) Canada $0.109B 0.00
Starpharma Holdings (SPHRY) Australia $0.109B 0.00
Oncolytics Biotech (ONCY) Canada $0.105B 0.00
Turn Therapeutics (TTRX) United States $0.103B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.103B 0.00
Citius Oncology (CTOR) United States $0.102B 0.00
Pliant Therapeutics (PLRX) United States $0.101B 0.00
Kalaris Therapeutics (KLRS) United States $0.101B 0.00
Leap Therapeutics (CYPH) United States $0.101B 0.00
Quince Therapeutics (QNCX) United States $0.100B 0.00
Whitehawk Therapeutics (WHWK) United States $0.100B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.097B 0.00
TuHURA Biosciences (HURA) United States $0.096B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.096B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.095B 0.00
Atara Biotherapeutics (ATRA) United States $0.094B 6.01
Adverum Biotechnologies (ADVM) United States $0.094B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.094B 0.00
Chrome Holding (MEHCQ) United States $0.094B 0.00
Repare Therapeutics (RPTX) Canada $0.094B 0.00
Ovid Therapeutics (OVID) United States $0.093B 0.00
Adicet Bio (ACET) United States $0.091B 0.00
Clene (CLNN) United States $0.089B 0.00
Immunic (IMUX) United States $0.088B 0.00
Instil Bio (TIL) United States $0.087B 0.00
Artiva Biotherapeutics (ARTV) United States $0.086B 0.00
Adagene (ADAG) China $0.086B 0.00
ALX Oncology Holdings (ALXO) United States $0.085B 0.00
InflaRx (IFRX) Germany $0.083B 0.00
BeyondSpring (BYSI) United States $0.083B 0.00
Biomea Fusion (BMEA) United States $0.082B 0.00
Fortress Biotech (FBIO) United States $0.081B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.081B 0.00
OKYO Pharma (OKYO) $0.081B 0.00
Annovis Bio (ANVS) United States $0.080B 0.00
Oncobiologics (OTLK) United States $0.079B 0.00
Tevogen Bio Holdings (TVGN) United States $0.076B 0.00
CervoMed (CRVO) United States $0.076B 0.00
XBiotech (XBIT) United States $0.075B 0.00
Sutro Biopharma (STRO) United States $0.072B 0.00
ABVC BioPharma (ABVC) United States $0.070B 0.00
Estrella Immunopharma (ESLA) United States $0.070B 0.00
Vor Biopharma (VOR) $0.069B 0.00
Precision BioSciences (DTIL) United States $0.068B 0.00
ATyr Pharma (ATYR) United States $0.067B 0.00
Equillium (EQ) United States $0.064B 0.00
BioAtla (BCAB) United States $0.060B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
MiNK Therapeutics (INKT) United States $0.056B 0.00
BioStem Technologies (BSEM) $0.056B 3.94
TScan Therapeutics (TCRX) United States $0.055B 0.00
Spruce Biosciences (SPRB) United States $0.055B 0.00
Medicus Pharma (MDCX) United States $0.051B 0.00
IO Biotech (IOBT) Denmark $0.047B 0.00
TELA Bio (TELA) United States $0.046B 0.00
Kezar Life Sciences (KZR) United States $0.046B 0.00
CalciMedica (CALC) United States $0.045B 0.00
Cue Biopharma (CUE) United States $0.045B 0.00
Skye Bioscience (SKYE) United States $0.045B 0.00
Werewolf Therapeutics (HOWL) United States $0.045B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.043B 0.00
OnKure Therapeutics (OKUR) United States $0.043B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Radiopharm Theranostics - (RADX) Australia $0.042B 0.00
Applied Therapeutics (APLT) United States $0.041B 0.00
Celularity (CELU) United States $0.041B 0.00
Genenta Science S.p.A (GNTA) Italy $0.039B 0.00
INmune Bio (INMB) United States $0.039B 0.00
Senti Biosciences (SNTI) United States $0.038B 0.00
PDS Biotechnology (PDSB) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.038B 0.00
Tvardi Therapeutics (TVRD) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
SAB Biotherapeutics (SABS) United States $0.036B 0.00
Generation Bio (GBIO) United States $0.036B 0.00
Hyperion DeFi (HYPD) United States $0.034B 0.00
Pluri (PLUR) Israel $0.034B 0.00
Alterity Therapeutics - (ATHE) Australia $0.034B 0.00
Tenax Therapeutics (TENX) United States $0.034B 0.00
Dyadic (DYAI) United States $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.032B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.031B 0.00
Elutia (ELUT) United States $0.031B 0.00
ImageneBio (IMA) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Galecto (GLTO) Denmark $0.030B 0.00
RenovoRx (RNXT) United States $0.029B 0.00
BioXcel Therapeutics (BTAI) United States $0.029B 0.00
Jasper Therapeutics (JSPR) United States $0.029B 0.00
Passage Bio (PASG) United States $0.029B 0.00
Q32 Bio (QTTB) United States $0.028B 0.00
Quantum Biopharma (QNTM) Canada $0.028B 0.00
NextCure (NXTC) United States $0.027B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.027B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Rallybio (RLYB) United States $0.026B 0.00
Femasys (FEMY) United States $0.026B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
Intensity Therapeutics (INTS) United States $0.025B 0.00
IBio (IBIO) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.024B 0.00
Apollomics (APLM) United States $0.024B 0.00
Exicure (XCUR) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Cingulate (CING) United States $0.023B 0.00
Lexaria Bioscience (LEXX) Canada $0.022B 0.00
Synaptogenix (TAOX) United States $0.022B 0.00
Moleculin Biotech (MBRX) United States $0.022B 0.00
Tharimmune (THAR) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Synlogic (SYBX) United States $0.020B 0.00
Promis Neurosciences (PMN) Canada $0.019B 0.00
Lisata Therapeutics (LSTA) United States $0.018B 0.00
MetaVia (MTVA) United States $0.018B 0.00
Hoth Therapeutics (HOTH) United States $0.018B 0.00
Athira Pharma (ATHA) United States $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.018B 0.00
Clearside Biomedical (CLSD) United States $0.017B 0.00
FibroBiologics (FBLG) United States $0.017B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.017B 0.00
Curis (CRIS) United States $0.016B 0.00
NewcelX (NCEL) Switzerland $0.016B 0.00
Abpro Holdings (ABP) United States $0.016B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.015B 0.00
BRIACELL THERAP (BCTX) Canada $0.015B 0.00
Longeveron (LGVN) United States $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
Revelation Biosciences (REVB) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.013B 0.00
Dogwood Therapeutics (DWTX) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Beyond Air (XAIR) United States $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Biofrontera (BFRI) United States $0.010B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.010B 0.00
Purple Biotech (PPBT) Israel $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Gelteq (GELS) Australia $0.009B 0.00
Acurx Pharmaceuticals (ACXP) $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Aprea Therapeutics (APRE) United States $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Ensysce Biosciences (ENSC) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Black Titan (BTTC) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Alps Group (ALPS) United States $0.003B 2.71
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
GT Biopharma (GTBP) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00